Also from this source

You just read:

Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis

News provided by

Sanofi-aventis

Oct 26, 2010, 01:00 ET